Pharmacy Track: Drug Pricing
Wednesday, September 22, 2021 12:00 PM - 1:00 PM ET
Speakers: Steven Schnelle and Dr. Rodney Whitlock
According to the National Academy for State Health Policy, more than 45 states have enacted laws relating to drug pricing since 2017. While the end goal is to lower drug costs through greater pricing transparency and more efficient distribution models, these complex and varied laws have a deep impact on pharmacy leaders. We’ll review the current state of drug pricing laws at the national and state level, discuss changes to drug pricing in 2022, and explore strategies to manage changes to drug pricing.
- Outline current federal and state laws as well as proposed legislation impacting drug pricing.
- Analyze expected drug pricing changes in 2022.
- Evaluate strategies to manage and comply with differing laws and regulations.
McDermott Will & Emery LLP
Steven Schnelle focuses his practice on regulatory and transactional matters involving healthcare providers and suppliers, pharmacies, pharmaceutical firms, device manufacturers, and market innovators. Steven provides counsel on a variety of healthcare regulatory and transactional matters, primarily focusing on issues involving the Centers for Medicare and Medicaid Services (CMS), the HHS Office of Inspector General (OIG), the Department of Justice (DOJ) and state agencies. He advises clients on complex reimbursement matters involving governmental and commercial payors, and he provides counsel on state licensing and credentialing issues, as well as corporate practice of the health professions. Steven represents clients in False Claims Act (FCA) qui tam matters, investigations and audits, and in matters involving compliance with the federal and state Anti-Kickback statutes. Steven regularly advises private equity firms, investment banks, commercial lenders, and healthcare and life science companies on healthcare regulatory issues relating to mergers and acquisitions, securities filings and financing in the United States.
Dr. Rodney Whitlock is an accomplished health care advisor with more than two decades on the Hill where he specialized in rural health, the health care safety net and disability policy. While working in Congress, Rodney served as former US Representative Charlie Norwood’s (R-GA) health policy director where he managed the Patients’ Bill of Rights (S.1890), among other notable health policy matters. Rodney then went on to serve Senator Chuck Grassley (R-IA) in the Senate. He first joined the Senate Finance Committee Staff as a health policy advisor to Chairman Grassley, and ultimately joined the Senator’s personal office as health policy director. For the last 20 years, Rodney has been an adjunct faculty member at the George Washington University Milken Institute School of Public Health’s Department of Health Policy and Management, and the Graduate School of Political Management’s Department of Legislative Affairs.